Saturday 17 October 2026 Export BBLG’s income statement to Excel — free account

Bone Biologics Corp.

BBLG Healthcare Biotechnology

In the quarter to June 2026, EPS grew 67.7% and free cash flow fell 13.0%, each against the same quarter a year earlier.

0.40 0.01 +2.56%

Follow BBLG

Alert me

Market cap: $1.1M
P/E: 0.0×
Fwd P/E: —
Dividend yield: —
F-score: n/a
Altman Z: n/a
Beneish M: n/a
Dividend safety: n/a

Overview Business Profile Financial Analysis Income Statement Balance Sheet Cash Flow Metrics & Ratios 10-Q 10-K

	Older periods	Sep '25	Dec '25	Mar '26	Jun '26
ROE Full definition →	+8 more TTM periods Free account	(80.46%)	(70.17%)	(75.40%)	(54.96%)
ROA Full definition →		(75.76%)	(64.38%)	(70.20%)	(50.55%)
ROIC Full definition →		0.00%	(4,680.27%)	(1,340.96%)	0.00%
Return on Tangible Assets Full definition →		(65.59%)	(57.81%)	(61.20%)	(73.66%)
Average Days of Receivables Full definition →		—	0.00	0.00	0.00
Free Cash Flow per Share Full definition →		(1.85)	(2.29)	(1.43)	(1.46)
Free Cash Flow Full definition →		(3.33)	(2.69)	(2.57)	(2.63)
Other line items
Cash ROIC Full definition →		(27.60%)	(25.12%)	(27.93%)	(33.04%)
Accounts Payable Turnover Full definition →		0.00	0.00	0.00	0.00
Average Days of Payables Full definition →		0.00	0.00	0.00	0.00
Tax Rate Full definition →		0.00	0.00	0.00	0.00
Research and Development Expense of Revenue Full definition →		0.00%	0.00%	0.00%	0.00%
Selling, General and Administrative Expense of Revenue Full definition →		0.00%	0.00%	0.00%	0.00%
Share Based Compensation of Revenue Full definition →		0.00%	0.00%	0.00%	0.00%
Operating CF/Net income Full definition →		0.84	0.87	0.90	0.91
Revenue per Share Full definition →		0.00	0.00	0.00	0.00
Operating CF per Share Full definition →		(1.85)	(2.29)	(1.43)	(1.46)
Capex per Share Full definition →		0.00	0.00	0.00	0.00

Show all line items

Columns are period end dates